Back

Learner’s Digest International (TM)

  • Carcinoid Tumor
  • Neuroendocrine Tumors
  • Optical Imaging
  • Positron-Emission Tomography
  • Somatostatin

Recent Advancements in Imaging and Treatment Options of Neuroendocrine Tumors

The goal of this program is to improve diagnosis and management of neuroendocrine tumors (NETs). After hearing and assimilating this program, the clinician will be better able to:Assess somatostatin receptor expression in NETs.Utilize DOTATATE positron emission tomography to determine candidacy for therapy for NETs.Evaluate use of near-infrared fluorescent autofluorescence imaging in the treatment of small bowel carcinoid tumors.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABS — Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Feb 8, 2027 4 months left